<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/055E428B-EF35-46E3-83A6-4D4004294C32"><gtr:id>055E428B-EF35-46E3-83A6-4D4004294C32</gtr:id><gtr:name>University of Utah</gtr:name><gtr:address><gtr:line1>201 South Presidents Circle</gtr:line1><gtr:line2>Salt Lake City</gtr:line2><gtr:line4>Utah</gtr:line4><gtr:postCode>UT 84112</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:department>Immunology Infection and Inflam Diseases</gtr:department><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/055E428B-EF35-46E3-83A6-4D4004294C32"><gtr:id>055E428B-EF35-46E3-83A6-4D4004294C32</gtr:id><gtr:name>University of Utah</gtr:name><gtr:address><gtr:line1>201 South Presidents Circle</gtr:line1><gtr:line2>Salt Lake City</gtr:line2><gtr:line4>Utah</gtr:line4><gtr:postCode>UT 84112</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/340AFC6A-4E6F-467A-B184-E775A92259B4"><gtr:id>340AFC6A-4E6F-467A-B184-E775A92259B4</gtr:id><gtr:firstName>Juan</gtr:firstName><gtr:surname>Martin-Serrano</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0802777"><gtr:id>B07E5D9A-98F8-413E-8E41-AEF6CB4BE340</gtr:id><gtr:title>Mechanisms within the ESCRT machinery required for HIV-1 budding</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0802777</gtr:grantReference><gtr:abstractText>Production of infectious Human Immunodeficiency Virus-1 (HIV-1) requires the separation of the nascent viral particle from the infected cell at the end of the assembly process. This late event in HIV-1 replication requires the resolution of a membrane tether by specialized cellular proteins, namely the Endosomal Sorting Complex Required for Transport (ESCRT) machinery. Importantly, there is a growing list of pathogenic viruses that also require the ESCRT machinery for replication, including Ebola virus, Hepatitis B virus, Herpes Simplex virus type 1, human T-cell leukemia virus type 1 (HTLV-1), Lassa virus and Parainfluenza virus 5. Hence, the pharmacological inhibition of the ESCRT machinery may offer a unique therapeutic opportunity to treat a broad range of pathogenic viral infections. However, there are obvious toxicity mechanisms for future inhibitors of the ESCRT pathway as it is primarily involved in essential aspects of cell biology, including the resolution of a membrane tether that connects the daughter cells at the final stage of cell division. The general aim of this research grant is to delineate specific mechanisms within the ESCRT machinery that are required for HIV-1 replication as opposed to this machinery?s role in cellular functions. These studies are needed to understand essential mechanisms of HIV-1 replication and cell biology and they will also contribute to determine the therapeutic potential of the ESCRT-machinery.</gtr:abstractText><gtr:technicalSummary>The last event in the assembly of infectious Human Immunodeficiency Virus (HIV-1) requires a membrane scission event that separates the nascent viral particle from the infected cell. This process is mediated by a late budding activity (L-domain) encoded by a short aminoacid motif (P/SAP) in the structural viral protein gag. It is now established that the HIV-1 L-domain facilitates egress via the recruitment of the Endosomal Complex Required for Transport (ESCRT) machinery. Moreover, there is a growing list of pathogenic human enveloped viruses that also require the ESCRT machinery for replication, namely Ebola virus, Hepatitis B virus, Herpes Simplex Virus type 1, HTLV-1, Lassa virus and Parainfluenza Virus 5. Consequently, the pharmacologic inhibition of the ESCRT machinery may offer a therapeutic opportunity against a broad range of enveloped viruses, but the fact that the ESCRT complexes are primarily involved in essential aspects of cell biology such as endosomal sorting into the Multivesicular Bodies and the resolution of the midbody at the end of cell division raises obvious potential mechanisms of toxicity for future inhibitors of the ESCRT machinery. Therefore, understanding the mechanisms underpinning the functional complexity within the ESCRT machinery and its regulation is not only needed to determine the therapeutic potential of this pathway, but also to further illuminate basic aspects of HIV-1 pathogenesis and cell biology. Thus, the general aim of this research grant application is to define the specific mechanisms within the ESCRT machinery that are required for HIV-1 budding as opposed to the role of this machinery in cytokinesis and endosomal sorting.</gtr:technicalSummary><gtr:fund><gtr:end>2015-07-05</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-01-06</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>967648</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Utah</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Collaboration with Professor Wes Sundquist</gtr:description><gtr:id>1A31FE0E-3A6B-4A70-BA72-8E4AFD8CBAD6</gtr:id><gtr:impact>Caballe A, Wenzel DM, Agromayor M, Alam SL, Skalicky JJ, Kloc M, Carlton JG, Labrador L, Sundquist WI*, Martin-Serrano J*. ULK3 regulates cytokinetic abscission by phosphorylating ESCRT-III proteins. Elife. 2015 May 26;4:e06547.</gtr:impact><gtr:outcomeId>58ca7d06816a97.53933437-1</gtr:outcomeId><gtr:partnerContribution>Biochemical and structural charaacterization of ULK3</gtr:partnerContribution><gtr:piContribution>Identification and functional characterization of ULK3 as a kinase that regulates cytokinesis via the phosphorylation of ESCRT-III</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Laboratory of Molecular Biology</gtr:department><gtr:description>Collaboration with Roger Williams at the MRC LMB</gtr:description><gtr:id>3CA1A368-2705-4FFB-B140-84F799609975</gtr:id><gtr:impact>Agromayor M, Soler N, Caballe A, Kueck T, Freund SM, Allen MD, Bycroft M, Perisic O, Ye Y, McDonald B, Scheel H, Hofmann K, Neil SJ, Martin-Serrano J*, Williams RL*. The UBAP1 subunit of ESCRT-I interacts with ubiquitin via a SOUBA domain. Structure. 2012 Mar 7;20(3):414-28</gtr:impact><gtr:outcomeId>58ca77f452dcf4.44858389-1</gtr:outcomeId><gtr:partnerContribution>Structural and biochemical characterization of UBAP1 as a novel subunit of ESCRT-I</gtr:partnerContribution><gtr:piContribution>Functional characterization of UBAP1 as a novel subunit of ESCRT-I</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Laboratory of Molecular Biology (LMB)</gtr:department><gtr:description>Collaboration with Roger Williams at the MRC LMB</gtr:description><gtr:id>3472A142-4F9E-4E5F-9C88-AF19009B637B</gtr:id><gtr:impact>Hadders MA, Agromayor M, O Takayuki, Perisic O, Caballe A, Kloc M, Lamers MH, Williams RL, Martin-Serrano J*. The ESCRT-III binding protein MITD1 is involved in cytokinesis and has an unanticipated PLD-fold that binds membranes. Proc Natl Acad Sci U S A. 2012, Oct 23; 109 (43):17424-9.</gtr:impact><gtr:outcomeId>58ca78ec2ad366.83176285-1</gtr:outcomeId><gtr:partnerContribution>Structural and biochemical characterization of MITD1</gtr:partnerContribution><gtr:piContribution>Functional characterization of MITD1 as a new component of the ESCRT pathway</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1299251</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Senior Investigator Award</gtr:description><gtr:end>2019-06-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>WT102871MA</gtr:fundingRef><gtr:id>D6CEDC9F-221C-4A7B-BA9D-A91CEF2981B8</gtr:id><gtr:outcomeId>5461e0ee369b87.26893621</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>967648</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Research Grant G0802777</gtr:description><gtr:end>2015-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>630EA76B-13A7-4BCC-86F2-3CB04313B45F</gtr:id><gtr:outcomeId>r5AM8FDqUif0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>259231</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Project Grant (Uncovering the role of MITD1 in ESCRT function)</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>WT093056</gtr:fundingRef><gtr:id>CD2B00C1-04BD-4A81-9126-2F6A44CD0AB7</gtr:id><gtr:outcomeId>CssJtuWYzvR0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Our laboratory has created many plasmids encoding fusions of the ESCRT subunits to various tags, such as fluorescent proteins, GST, yeast two hybrid, etc</gtr:description><gtr:id>78AE15A3-8C4A-44C0-9181-A0D462E9C788</gtr:id><gtr:impact>We constantly share these plasmids on request with many research groups that work in several areas of research, such as virology and cell biology</gtr:impact><gtr:outcomeId>B0DF232C3FA</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Plasmids encoding several variations of the ESCRT subunits</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Our laboratory has created many plasmids encoding fusions of the ESCRT subunits to various tags, such as fluorescent proteins, GST, yeast two hybrid, etc</gtr:description><gtr:id>0BAE5A89-5E03-4EAA-83C3-BA09004F4301</gtr:id><gtr:impact>We constantly share these plasmids on request with many research groups that work in several areas of research, such as virology and cell biology</gtr:impact><gtr:outcomeId>BXFBwPAqLuD</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Plasmids encoding several variations of the ESCRT subunits</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>These are stable cell lines expressing a fluorescent versions of several components of the ESCRT machinery and other interacting proteins</gtr:description><gtr:id>F07F4E3D-5074-4277-877B-425C5C323844</gtr:id><gtr:impact>These cell lines have been shared with several researchers that are investigating the role of cellular proteins in HIV-1 replication and cytokinesis.</gtr:impact><gtr:outcomeId>20A11A5B348</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Hela YFP-Tsg101, Hela Cherry-Cep55, Hela YFP-ALIX</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>3B4D7B01-3741-4CF4-AC3D-39D78BD9F5DB</gtr:id><gtr:title>ESCRT-III binding protein MITD1 is involved in cytokinesis and has an unanticipated PLD fold that binds membranes.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ef589004c3149e1d085d244be7eb3d9"><gtr:id>3ef589004c3149e1d085d244be7eb3d9</gtr:id><gtr:otherNames>Hadders MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_15288_28_23045692</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AFE3B737-8055-40AD-BEEB-2E957E683A80</gtr:id><gtr:title>ULK3 regulates cytokinetic abscission by phosphorylating ESCRT-III proteins.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/871ce669a51edbea51c4d9082512ddff"><gtr:id>871ce669a51edbea51c4d9082512ddff</gtr:id><gtr:otherNames>Caballe A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>5675e5361d644</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>207806F1-44FD-43E3-AF2F-7E812B523617</gtr:id><gtr:title>SNX15 links clathrin endocytosis to the PtdIns3P early endosome independently of the APPL1 endosome.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dd1ba89c410372a5beab62e12e80788e"><gtr:id>dd1ba89c410372a5beab62e12e80788e</gtr:id><gtr:otherNames>Danson C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>pm_15288_28_23986476</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3B196412-A12B-408A-9234-89149E695F3C</gtr:id><gtr:title>Multiple interactions between the ESCRT machinery and arrestin-related proteins: implications for PPXY-dependent budding.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a92e56006968a52026502d2da6f3307"><gtr:id>6a92e56006968a52026502d2da6f3307</gtr:id><gtr:otherNames>Rauch S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>bPeZNbwV7mJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9BF05B16-F43E-408D-A405-40B99650CB31</gtr:id><gtr:title>ESCRT machinery: Damage control at the nuclear membrane.</gtr:title><gtr:parentPublicationTitle>Cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/491c5321f906d31558489a5702525311"><gtr:id>491c5321f906d31558489a5702525311</gtr:id><gtr:otherNames>Ventimiglia LN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1001-0602</gtr:issn><gtr:outcomeId>58ca6fa7a4bf37.08505407</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23A1AB26-A76A-4B0B-8CA3-7287F5E4DE35</gtr:id><gtr:title>ESCRT-III governs the Aurora B-mediated abscission checkpoint through CHMP4C.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/43118aa955965c0754d2fec188730444"><gtr:id>43118aa955965c0754d2fec188730444</gtr:id><gtr:otherNames>Carlton JG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>pm_15288_28_22422861</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>241087C9-1CE7-4F32-9190-0BD2594606AB</gtr:id><gtr:title>The UBAP1 subunit of ESCRT-I interacts with ubiquitin via a SOUBA domain.</gtr:title><gtr:parentPublicationTitle>Structure (London, England : 1993)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ccc6e00645d6982afab2e48beee2007f"><gtr:id>ccc6e00645d6982afab2e48beee2007f</gtr:id><gtr:otherNames>Agromayor M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0969-2126</gtr:issn><gtr:outcomeId>pm_15288_28_22405001</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7E52114-DDEF-4850-9554-29D2C1BA1F4F</gtr:id><gtr:title>Knowing when to cut and run: mechanisms that control cytokinetic abscission.</gtr:title><gtr:parentPublicationTitle>Trends in cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ccc6e00645d6982afab2e48beee2007f"><gtr:id>ccc6e00645d6982afab2e48beee2007f</gtr:id><gtr:otherNames>Agromayor M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0962-8924</gtr:issn><gtr:outcomeId>pm_15288_28_23706391</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62347D6B-99EB-4C7A-BC5B-84A955D1FD78</gtr:id><gtr:title>An ESCRT module is required for neuron pruning.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7022bd3e5a8c3f230f28fa2fec8f07e"><gtr:id>c7022bd3e5a8c3f230f28fa2fec8f07e</gtr:id><gtr:otherNames>Loncle N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5675dfb286138</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C95F4156-457D-43F7-84DE-6E621C051137</gtr:id><gtr:title>ESCRT machinery and cytokinesis: the road to daughter cell separation.</gtr:title><gtr:parentPublicationTitle>Traffic (Copenhagen, Denmark)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/871ce669a51edbea51c4d9082512ddff"><gtr:id>871ce669a51edbea51c4d9082512ddff</gtr:id><gtr:otherNames>Caballe A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1398-9219</gtr:issn><gtr:outcomeId>R1iNUPSsa1b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF347123-B11C-49DD-82A6-87BD47FFD563</gtr:id><gtr:title>Host factors involved in retroviral budding and release.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/394e175a960f6fd2f11dd2eb059ea9ef"><gtr:id>394e175a960f6fd2f11dd2eb059ea9ef</gtr:id><gtr:otherNames>Martin-Serrano J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1740-1526</gtr:issn><gtr:outcomeId>bFjipZEYKoz</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0802777</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>